The Incannex Healthcare Ltd [ASX:IHL] share price has risen 6.17% today, to trade at 8.6 cents at the time of writing. The Melbourne-based cannabinoid pharmaceuticals company announced record sales for the September quarter of 2020.
From the low in April 2020, the share price has moved up over 138% to where it is today, all this on the back of a rather exciting 12 months for the company. Looking back to August 2019, Impressions Healthcare announced they had officially launched their wholly-owned, novel cannabinoid drug discovery brand, Incannex...
Earlier in the day, the Impression Healthcare share price was up by around 30%, to 2.6 cents per share. The share price has dipped a little to trade at 2.2 cents at the time of writing. That said, this could be the start of a massive share price run.
After lodging its medical cannabis license application, Impression Healthcare's share price has jumped 5.56%. The lodgement represents a significant milestone in Impression Healthcare’s medical cannabinoid strategy.
At the time of writing, shares of Impression Health Ltd [ASX:IHL] are up by 66.67%, to 2.5 cents per share. The share price rocketed to hit 3.7 cents per share earlier today.